×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
×
Welcome to visit Clinical Medication Journal!
Quick Search
Nianqi Search
Adv Search
Toggle navigation
Home
About
Journal Information
办刊宗旨
Editorial Board
Office Platform
Announcement
Advertising
Dynamic
Subscription
Contact Us
Long-term efficacy and safety of personalized P2Y
12
receptor antagonists according to CYP2C19 genotype for patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a Meta-analysis
FANG Zhen-wei, SHI Xiu-jin, ZHAO Zi-nan, DING Zheng, WEI Juan-juan, ZHOU Yang, LIN Bai-di, ZHOU Peng-xiang, LIN Yang
CLINICAL MEDICATION JOURNAL . 2022, (
1
): 43 -52 . DOI: 10.3969/j.issn.1672-3384.2022.01.005